NCT03310424

Brief Summary

Syphilis is an important sexually transmitted infection. There has been an epidemic of syphilis amongst men who have sex with men in the United Kingdom in the last decade. Early infection with syphilis causes a genital ulcer followed, in the absence of treatment, by a generalised illness often accompanied by rash. Studies on the pathogenesis of syphilis have been limited because it is not possible to grow syphilis outside of the body. New approaches using molecular tests allow the immune response of the patient to infection to be measured directly from a swab of a genital ulcer or rash and/or a blood sample and also allow the whole genetic sequence of the bacteria to be obtained from a swab. In this study the investigators will collect swabs from ulcers or rashes and a blood sample from patients with syphilis and measure both the response of the patient immune system and the genetic sequence of the bacteria. Patients will be enrolled at sexual health clinics in the United Kingdom. Patients will receive standard medical care including standard treatment for syphilis in line with national guidelines. Standard management already includes collection of a swab and a blood sample. For this study an additional swab sample and an additional 5ml of blood will be collected for use in this research project. By better understanding host immune system responds to infection with syphilis the studies aims to gain better insights in to the pathogenesis of this important sexually transmitted disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 16, 2017

Completed
11 days until next milestone

Study Start

First participant enrolled

October 27, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

1.8 years

First QC Date

October 11, 2017

Last Update Submit

October 4, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Whole Genome Sequencing

    Whole Genome Sequencing of T.pallidum

    From samples collected at baseline

  • Host Transcriptomic Response

    RNA Sequencing from lesion and blood samples

    From samples collected at baseline

Interventions

No active intervention is undertaken. Collection of samples for bio-informatic analysis only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Early infectious syphilis with exudative skin/genital lesions from which a lesion swab can be obtained

You may qualify if:

  • Early infectious syphilis with exudative skin/genital lesions from which a lesion swab can be obtained

You may not qualify if:

  • Age \<18 years
  • Unable to provide consent
  • Patients with other stages of syphilis apart from Primary or Secondary OR patients without a lesion from which swabs can be obtained

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mortimer Market Centre

London, WC1E 6JB, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood and Lesion Swab samples

MeSH Terms

Conditions

Syphilis

Condition Hierarchy (Ancestors)

Treponemal InfectionsSpirochaetales InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSexually Transmitted Diseases, BacterialSexually Transmitted DiseasesCommunicable DiseasesGenital DiseasesUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2017

First Posted

October 16, 2017

Study Start

October 27, 2017

Primary Completion

July 30, 2019

Study Completion

August 1, 2024

Last Updated

October 5, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Locations